More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Enoblituzumab (Anti-B7-H3 / CD276)

Enoblituzumab (Anti-B7-H3 / CD276)

A2626
Selleck Chemicals
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Selleck Chemicals
  • Product Name
    Enoblituzumab (Anti-B7-H3 / CD276)
  • Delivery Days Customer
    9
  • Certification
    Research Use Only
  • Estimated Purity
    ...
  • Scientific Description
    Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1kappa monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203